Kyoto, Japan

Keiji Ogura

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keiji Ogura. Retrieved from https://idiyas.com/inventor/keiji-ogura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keiji Ogura: Pioneering Innovations in Antifungal Medicines

Introduction:

Keiji Ogura, a dedicated inventor hailing from Kyoto, JP, is renowned for his unwavering commitment to innovation in the field of pharmaceuticals. With a passion for pushing the boundaries of technology, Ogura has solidified his position as a true pioneer, inspiring future generations of inventors.

Latest Patents:

Ogura's groundbreaking patent, "Biaryl derivative and medicine containing the same," showcases his ingenuity in developing compounds with exceptional antifungal properties. This innovation targets fungi responsible for superficial mycosis, offering high effectiveness against various fungal diseases.

Career Highlights:

Throughout his illustrious career, Ogura has been a driving force at Kaken Pharmaceutical Company, Ltd.. His relentless pursuit of excellence has led to the successful development of novel pharmaceutical compounds, revolutionizing the treatment of fungal infections. Ogura's dedication to advancing medical science has garnered him respect and admiration within the industry.

Collaborations:

At Kaken Pharmaceutical Company, Ltd., Ogura collaborates closely with esteemed colleagues such as Atsushi Watanabe and Yuuki Sato. Together, they form a dynamic team that fosters creativity and innovation, leading to groundbreaking discoveries in the field of pharmaceutical research.

Conclusion:

Keiji Ogura's remarkable contributions to the field of pharmaceuticals underscore his status as a visionary inventor. His innovative spirit, coupled with a strong commitment to advancing technology, continues to shape the future of antifungal medications. Ogura's legacy serves as a beacon of inspiration for aspiring inventors worldwide, paving the way for transformative advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…